Knoll Capital Management’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-3,750
| Closed | -$152K | – | 35 |
|
|
2023
Q3 | $152K | Buy |
3,750
+1,875
| +100% | +$75.9K | 0.16% | 36 |
|
|
2023
Q2 | $200K | Buy |
+1,875
| New | +$200K | 0.24% | 26 |
|
|
2022
Q4 | – | Sell |
-1,250
| Closed | -$236K | – | 25 |
|
|
2022
Q3 | $236K | Hold |
1,250
| – | – | 0.14% | 29 |
|
|
2022
Q2 | $92K | Hold |
1,250
| – | – | 0.05% | 37 |
|
|
2022
Q1 | $418K | Hold |
1,250
| – | – | 0.26% | 32 |
|
|
2021
Q4 | $407K | Hold |
1,250
| – | – | 0.22% | 28 |
|
|
2021
Q3 | $607K | Hold |
1,250
| – | – | 0.3% | 25 |
|
|
2021
Q2 | $581K | Hold |
1,250
| – | – | 0.3% | 30 |
|
|
2021
Q1 | $863K | Hold |
1,250
| – | – | 0.56% | 26 |
|
|
2020
Q4 | $924K | Hold |
1,250
| – | – | 0.63% | 18 |
|
|
2020
Q3 | $867K | Hold |
1,250
| – | – | 0.71% | 16 |
|
|
2020
Q2 | $1.07M | Hold |
1,250
| – | – | 0.62% | 17 |
|
|
2020
Q1 | $447K | Buy |
+1,250
| New | +$447K | 0.42% | 18 |
|